TY - JOUR
T1 - How good are the outcomes of instrumented debulking operations for symptomatic spinal metastases and how long do they stand? A subgroup analysis in the global spine tumor study group database
AU - Depreitere, Bart
AU - Ricciardi, Federico
AU - Arts, Mark
AU - Balabaud, Laurent
AU - Bunger, Cody
AU - Buchowski, Jacob M.
AU - Chung, Chun Kee
AU - Coppes, Maarten Hubert
AU - Fehlings, Michael George
AU - Kawahara, Norio
AU - Martin-Benlloch, Juan Antonio
AU - Massicotte, Eric Maurice
AU - Mazel, Christian
AU - Meyer, Bernhard
AU - Oner, Fetullah Cumhur
AU - Peul, Wilco
AU - Quraishi, Nasir
AU - Tokuhashi, Yasuaki
AU - Tomita, Katsuro
AU - Verlaan, Jorrit Jan
AU - Wang, Michael
AU - Crockard, Hugh Alan
AU - Choi, David
N1 - Funding Information:
This work was funded by the Global Spine Tumor Study Group, a registered charity of England and Wales, Charity Commission number 1134934, and DePuy Synthes (Johnson and Johnson). This study was performed in part at University College London Biomedical Research Centre, which receives funding from the National Institute for Health Research, UK. The sponsors had no role in the design or conduct of this research.
Publisher Copyright:
© 2020, Springer-Verlag GmbH Austria, part of Springer Nature.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Background: The benefits of surgery for symptomatic spinal metastases have been demonstrated, largely based on series of patients undergoing debulking and instrumentation operations. However, as cancer treatments improve and overall survival lengths increase, the incidence of recurrent spinal cord compression after debulking may increase. The aim of the current paper is to document the postoperative evolution of neurological function, pain, and quality of life following debulking and instrumentation in the Global Spine Tumor Study Group (GSTSG) database. Methods: The GSTSG database is a prospective multicenter data repository of consecutive patients that underwent surgery for a symptomatic spinal metastasis. For the present analysis, patients were selected from the database that underwent decompressive debulking surgery with instrumentation. Preoperative tumor type, Tomita and Tokuhashi scores, EQ-5D, Frankel, Karnofsky, and postoperative complications, survival, EQ-5D, Frankel, Karnofsky, and pain numeric rating scores (NRS) at 3, 6, 12, and 24 months were analyzed. Results: A total of 914 patients underwent decompressive debulking surgery with instrumentation and had documented follow-up until death or until 2 years post surgery. Median preoperative Karnofsky performance index was 70. A total of 656 patients (71.8%) had visceral metastases and 490 (53.6%) had extraspinal bone metastases. Tomita scores were evenly distributed above (49.1%) and below or equal to 5 (50.9%), and Tokuhashi scores almost evenly distributed below or equal to 8 (46.3%) and above 8 (53.7%). Overall, 12-month survival after surgery was 56.3%. The surgery resulted in EQ-5D health status improvement and NRS pain reduction that was maintained throughout follow-up. Frankel scores improved at first follow-up in 25.0% of patients, but by 12 months neurological deterioration was observed in 18.8%. Conclusion: We found that palliative debulking and instrumentation surgeries were performed throughout all Tomita and Tokuhashi categories. These surgeries reduced pain scores and improved quality of life up to 2 years after surgery. After initial improvement, a proportion of patients experienced neurological deterioration by 1 year, but the majority of patients remained stable.
AB - Background: The benefits of surgery for symptomatic spinal metastases have been demonstrated, largely based on series of patients undergoing debulking and instrumentation operations. However, as cancer treatments improve and overall survival lengths increase, the incidence of recurrent spinal cord compression after debulking may increase. The aim of the current paper is to document the postoperative evolution of neurological function, pain, and quality of life following debulking and instrumentation in the Global Spine Tumor Study Group (GSTSG) database. Methods: The GSTSG database is a prospective multicenter data repository of consecutive patients that underwent surgery for a symptomatic spinal metastasis. For the present analysis, patients were selected from the database that underwent decompressive debulking surgery with instrumentation. Preoperative tumor type, Tomita and Tokuhashi scores, EQ-5D, Frankel, Karnofsky, and postoperative complications, survival, EQ-5D, Frankel, Karnofsky, and pain numeric rating scores (NRS) at 3, 6, 12, and 24 months were analyzed. Results: A total of 914 patients underwent decompressive debulking surgery with instrumentation and had documented follow-up until death or until 2 years post surgery. Median preoperative Karnofsky performance index was 70. A total of 656 patients (71.8%) had visceral metastases and 490 (53.6%) had extraspinal bone metastases. Tomita scores were evenly distributed above (49.1%) and below or equal to 5 (50.9%), and Tokuhashi scores almost evenly distributed below or equal to 8 (46.3%) and above 8 (53.7%). Overall, 12-month survival after surgery was 56.3%. The surgery resulted in EQ-5D health status improvement and NRS pain reduction that was maintained throughout follow-up. Frankel scores improved at first follow-up in 25.0% of patients, but by 12 months neurological deterioration was observed in 18.8%. Conclusion: We found that palliative debulking and instrumentation surgeries were performed throughout all Tomita and Tokuhashi categories. These surgeries reduced pain scores and improved quality of life up to 2 years after surgery. After initial improvement, a proportion of patients experienced neurological deterioration by 1 year, but the majority of patients remained stable.
KW - Debulking surgery
KW - Frankel score
KW - Metastasis
KW - Quality of life
KW - Spine
UR - http://www.scopus.com/inward/record.url?scp=85078228450&partnerID=8YFLogxK
U2 - 10.1007/s00701-019-04197-5
DO - 10.1007/s00701-019-04197-5
M3 - Article
C2 - 31953690
AN - SCOPUS:85078228450
SN - 0001-6268
VL - 162
SP - 943
EP - 950
JO - Acta Neurochirurgica
JF - Acta Neurochirurgica
IS - 4
ER -